CYTOSORBENTS CORPORATION Operating Income
CYTOSORBENTS CORPORATION (CTSO) reported Operating Income of -$2.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- CYTOSORBENTS CORPORATION operating income (loss) for the quarter ending 2026-06-30 was -$2.64M.
- CYTOSORBENTS CORPORATION operating income (loss) for the quarter ending 2026-03-31 was -$3.04M.
- CYTOSORBENTS CORPORATION operating income (loss) for the quarter ending 2025-12-31 was -$4.38M.
- CYTOSORBENTS CORPORATION operating income (loss) for the quarter ending 2025-09-30 was -$2.86M.
- CYTOSORBENTS CORPORATION operating income (loss) for fiscal 2025 was -$14.75M.
- CYTOSORBENTS CORPORATION operating income (loss) for fiscal 2024 was -$16.45M.
- CYTOSORBENTS CORPORATION operating income (loss) for fiscal 2023 was -$31.95M.
- CYTOSORBENTS CORPORATION operating income (loss) for fiscal 2022 was -$31.52M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 179 month | Operating Income (Loss) 182 month | Operating Income (Loss) 185 month | Operating Income (Loss) 188 month | Operating Income (Loss) 191 month | Operating Income (Loss) 194 month | Operating Income (Loss) 197 month | Operating Income (Loss) 200 month | Operating Income (Loss) 203 month | Operating Income (Loss) 206 month | Operating Income (Loss) 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.64M 10-Q · filed 2026-08-06 | -$5.68M 10-Q · filed 2026-08-06 | -$10.07M derived: sum of 3 quarters · filed 2026-08-06 | -$12.93M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2026-03-31 | -$3.04M 10-Q · filed 2026-05-13 | -$7.43M derived: sum of 2 quarters · filed 2026-05-13 | -$10.29M derived: sum of 3 quarters · filed 2026-05-13 | -$13.91M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$7.25M derived: sum of 2 quarters · filed 2026-03-30 | -$10.86M derived: sum of 3 quarters · filed 2026-08-06 | -$14.75M 10-K · filed 2026-03-30 | |||||||||||||||
| 2025-09-30 | -$2.86M 10-Q · filed 2025-11-13 | -$6.48M derived: sum of 2 quarters · filed 2026-08-06 | -$10.36M 10-Q · filed 2025-11-13 | -$13.76M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-06-30 | -$3.62M 10-Q · filed 2026-08-06 | -$7.50M 10-Q · filed 2026-08-06 | -$10.90M derived: sum of 3 quarters · filed 2026-08-06 | -$15.73M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-03-31 | -$3.89M 10-Q · filed 2026-05-13 | -$3.89M 10-Q · filed 2025-05-14 | -$7.28M derived: sum of 2 quarters · filed 2026-05-13 | -$12.11M derived: sum of 3 quarters · filed 2026-05-13 | -$15.68M derived: sum of 4 quarters · filed 2026-05-13 | ||||||||||||||
| 2024-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$8.22M derived: sum of 2 quarters · filed 2026-03-30 | -$11.79M derived: sum of 3 quarters · filed 2026-03-30 | -$16.45M 10-K · filed 2026-03-30 | -$16.79M 10-K · filed 2025-03-31 | ||||||||||||||
| 2024-09-30 | -$4.83M 10-Q · filed 2025-11-13 | -$4.40M 10-Q · filed 2024-11-07 | -$8.40M derived: sum of 2 quarters · filed 2025-11-13 | -$13.06M 10-Q · filed 2025-11-13 | -$12.74M 10-Q · filed 2024-11-07 | -$22.46M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||||
| 2024-06-30 | -$3.57M 10-Q · filed 2025-08-07 | -$3.42M 10-Q · filed 2024-08-13 | -$8.23M 10-Q · filed 2025-08-07 | -$8.34M 10-Q · filed 2024-08-13 | -$17.63M derived: sum of 3 quarters · filed 2025-08-07 | -$24.98M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||||||
| 2024-03-31 | -$4.66M 10-Q · filed 2025-05-14 | -$4.93M 10-Q · filed 2024-05-09 | -$14.06M derived: sum of 2 quarters · filed 2025-05-14 | -$21.41M derived: sum of 3 quarters · filed 2025-05-14 | -$27.97M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||||||
| 2023-12-31 | -$9.41M 10-K · filed 2024-03-15 | -$16.76M derived: sum of 2 quarters · filed 2024-11-07 | -$23.32M derived: sum of 3 quarters · filed 2024-11-07 | -$31.95M 10-K · filed 2025-03-31 | -$31.21M 10-K · filed 2024-03-15 | ||||||||||||||
| 2023-09-30 | -$7.35M 10-Q · filed 2024-11-07 | -$13.91M derived: sum of 2 quarters · filed 2024-11-07 | -$21.87M 10-Q · filed 2024-11-07 | -$28.16M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||||
| 2023-06-30 | -$6.56M 10-Q · filed 2024-08-13 | -$14.45M 10-Q · filed 2024-08-13 | -$20.81M derived: sum of 3 quarters · filed 2024-08-13 | -$29.82M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||||||
| 2023-03-31 | -$7.89M 10-Q · filed 2024-05-09 | -$14.25M derived: sum of 2 quarters · filed 2024-05-09 | -$23.27M derived: sum of 3 quarters · filed 2024-05-09 | -$31.62M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||||||
| 2022-12-31 | -$6.36M 10-K · filed 2024-03-15 | -$15.37M derived: sum of 2 quarters · filed 2024-03-15 | -$23.73M derived: sum of 3 quarters · filed 2024-03-15 | -$31.52M 10-K · filed 2024-03-15 | |||||||||||||||
| 2022-09-30 | -$9.02M 10-K · filed 2024-03-15 | -$17.37M derived: sum of 2 quarters · filed 2024-03-15 | -$25.17M 10-Q · filed 2023-11-09 | -$34.73M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2022-06-30 | -$8.36M 10-K · filed 2024-03-15 | -$16.15M 10-Q · filed 2023-08-01 | -$25.71M derived: sum of 3 quarters · filed 2024-03-15 | -$31.12M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2022-03-31 | -$7.79M 10-K · filed 2024-03-15 | -$17.35M derived: sum of 2 quarters · filed 2024-03-15 | -$22.76M derived: sum of 3 quarters · filed 2024-03-15 | -$27.68M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2021-12-31 | -$9.56M 10-K · filed 2024-03-15 | -$14.97M derived: sum of 2 quarters · filed 2024-03-15 | -$19.89M derived: sum of 3 quarters · filed 2024-03-15 | -$22.74M 10-K · filed 2024-03-15 | |||||||||||||||
| 2021-09-30 | -$5.41M 10-K · filed 2024-03-15 | -$10.33M derived: sum of 2 quarters · filed 2024-03-15 | -$13.18M 10-Q · filed 2022-11-03 | -$15.82M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2021-06-30 | -$4.92M 10-K · filed 2024-03-15 | -$7.78M 10-Q · filed 2022-08-02 | -$10.41M derived: sum of 3 quarters · filed 2024-03-15 | -$12.37M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2021-03-31 | -$2.85M 10-K · filed 2024-03-15 | -$5.49M derived: sum of 2 quarters · filed 2024-03-15 | -$7.45M derived: sum of 3 quarters · filed 2024-03-15 | -$10.74M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||||||
| 2020-12-31 | -$2.63M 10-K · filed 2023-03-09 | -$4.59M derived: sum of 2 quarters · filed 2023-03-09 | -$7.89M derived: sum of 3 quarters · filed 2023-03-09 | -$10.37M 10-K · filed 2023-03-09 | |||||||||||||||
| 2020-09-30 | -$1.96M 10-K · filed 2023-03-09 | -$1.96M 10-Q · filed 2020-11-04 | -$5.26M derived: sum of 2 quarters · filed 2023-03-09 | -$7.74M 10-Q · filed 2021-11-04 | -$13.17M derived: sum of 4 quarters · filed 2023-03-09 | ||||||||||||||
| 2020-06-30 | -$3.30M 10-K · filed 2023-03-09 | -$5.78M 10-Q · filed 2021-08-03 | -$11.21M derived: sum of 3 quarters · filed 2023-03-09 | -$16.84M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||||||
| 2020-03-31 | -$2.48M 10-K · filed 2023-03-09 | -$7.91M derived: sum of 2 quarters · filed 2023-03-09 | -$13.54M derived: sum of 3 quarters · filed 2023-03-09 | -$17.17M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||||||
| 2019-12-31 | -$5.43M 10-K · filed 2022-03-10 | -$11.06M derived: sum of 2 quarters · filed 2022-03-10 | -$14.69M derived: sum of 3 quarters · filed 2022-03-10 | -$18.97M 10-K · filed 2022-03-10 | |||||||||||||||
| 2019-09-30 | -$5.63M 10-K · filed 2022-03-10 | -$9.26M derived: sum of 2 quarters · filed 2022-03-10 | -$13.54M 10-Q · filed 2020-11-04 | -$19.13M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||
| 2019-06-30 | -$3.63M 10-K · filed 2022-03-10 | -$7.92M 10-Q · filed 2020-08-04 | -$13.50M derived: sum of 3 quarters · filed 2022-03-10 | -$16.21M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||
| 2019-03-31 | -$4.29M 10-K · filed 2022-03-10 | -$9.87M derived: sum of 2 quarters · filed 2022-03-10 | -$12.58M derived: sum of 3 quarters · filed 2022-03-10 | -$16.77M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||||||
| 2018-12-31 | -$5.59M 10-K · filed 2021-03-09 | -$8.30M derived: sum of 2 quarters · filed 2021-03-09 | -$12.48M derived: sum of 3 quarters · filed 2021-03-09 | -$15.58M 10-K · filed 2021-03-09 | |||||||||||||||
| 2018-09-30 | -$2.71M 10-K · filed 2021-03-09 | -$2.71M 10-Q · filed 2018-11-06 | -$6.90M derived: sum of 2 quarters · filed 2021-03-09 | -$10.00M 10-Q · filed 2019-11-05 | -$13.80M derived: sum of 4 quarters · filed 2021-03-09 | ||||||||||||||
| 2018-06-30 | -$4.19M 10-K · filed 2021-03-09 | -$7.29M 10-Q · filed 2019-08-06 | -$11.09M derived: sum of 3 quarters · filed 2021-03-09 | -$13.24M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||||||
| 2018-03-31 | -$3.10M 10-K · filed 2021-03-09 | -$6.91M derived: sum of 2 quarters · filed 2021-03-09 | -$9.06M derived: sum of 3 quarters · filed 2021-03-09 | -$11.39M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||||||
| 2017-12-31 | -$3.81M 10-K · filed 2020-03-05 | -$5.95M derived: sum of 2 quarters · filed 2020-03-05 | -$8.29M derived: sum of 3 quarters · filed 2020-03-05 | -$9.84M 10-K · filed 2020-03-05 | |||||||||||||||
| 2017-09-30 | -$2.15M 10-K · filed 2020-03-05 | -$4.48M derived: sum of 2 quarters · filed 2020-03-05 | -$6.04M 10-Q · filed 2018-11-06 | -$10.61M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||||||
| 2017-06-30 | -$2.33M 10-K · filed 2020-03-05 | -$3.89M 10-Q · filed 2018-08-02 | -$8.46M derived: sum of 3 quarters · filed 2020-03-05 | -$10.60M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||||||
| 2017-03-31 | -$1.56M 10-K · filed 2020-03-05 | -$6.13M derived: sum of 2 quarters · filed 2020-03-05 | -$8.27M derived: sum of 3 quarters · filed 2020-03-05 | -$10.96M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||||||
| 2016-12-31 | -$4.57M 10-K · filed 2019-03-07 | -$6.71M derived: sum of 2 quarters · filed 2019-03-07 | -$9.40M derived: sum of 3 quarters · filed 2019-03-07 | -$11.49M 10-K · filed 2019-03-07 | |||||||||||||||
| 2016-09-30 | -$2.14M 10-K · filed 2019-03-07 | -$4.83M derived: sum of 2 quarters · filed 2019-03-07 | -$6.92M 10-Q · filed 2017-11-09 | -$9.14M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||
| 2016-06-30 | -$2.69M 10-K · filed 2019-03-07 | -$4.78M 10-Q · filed 2017-08-07 | -$6.99M derived: sum of 3 quarters · filed 2019-03-07 | -$9.14M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||
| 2016-03-31 | -$2.09M 10-K · filed 2019-03-07 | -$4.30M derived: sum of 2 quarters · filed 2019-03-07 | -$6.45M derived: sum of 3 quarters · filed 2019-03-07 | -$8.68M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||||||
| 2015-12-31 | -$2.21M 10-K · filed 2018-03-08 | -$4.36M derived: sum of 2 quarters · filed 2018-03-08 | -$6.59M derived: sum of 3 quarters · filed 2018-03-08 | -$9.30M 10-K · filed 2018-03-08 | |||||||||||||||
| 2015-09-30 | -$2.15M 10-K · filed 2018-03-08 | -$4.38M derived: sum of 2 quarters · filed 2018-03-08 | -$6.64M 10-Q · filed 2016-11-07 | -$9.98M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||
| 2015-06-30 | -$2.23M 10-K · filed 2018-03-08 | -$4.49M 10-Q · filed 2016-08-09 | -$7.83M derived: sum of 3 quarters · filed 2018-03-08 | -$9.31M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||
| 2015-03-31 | -$2.71M 10-K · filed 2018-03-08 | -$5.60M derived: sum of 2 quarters · filed 2018-03-08 | -$7.09M derived: sum of 3 quarters · filed 2018-03-08 | -$8.45M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||||||
| 2014-12-31 | -$2.89M 10-K · filed 2017-03-03 | -$4.38M derived: sum of 2 quarters · filed 2017-03-03 | -$5.74M derived: sum of 3 quarters · filed 2017-03-03 | -$6.89M 10-K · filed 2017-03-03 | -$7.28M 10-K · filed 2015-03-31 | ||||||||||||||
| 2014-09-30 | -$1.48M 10-K · filed 2017-03-03 | -$1.69M 10-Q · filed 2014-11-12 | -$2.85M derived: sum of 2 quarters · filed 2017-03-03 | -$3.99M 10-Q · filed 2015-11-13 | -$4.22M 10-Q · filed 2014-11-12 | -$5.01M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||||
| 2014-06-30 | -$1.36M 10-K · filed 2017-03-03 | -$1.38M 10-Q · filed 2014-08-12 | -$2.51M 10-Q · filed 2015-08-13 | -$2.54M 10-Q · filed 2014-08-12 | -$3.52M derived: sum of 3 quarters · filed 2017-03-03 | -$4.40M derived: sum of 4 quarters · filed 2017-03-03 | -$88.58M 10-Q · filed 2014-08-12 | ||||||||||||
| 2014-03-31 | -$1.15M 10-K · filed 2017-03-03 | -$2.16M derived: sum of 2 quarters · filed 2017-03-03 | -$3.04M derived: sum of 3 quarters · filed 2017-03-03 | -$4.45M derived: sum of 4 quarters · filed 2017-03-03 | -$87.19M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.88M derived: sum of 2 quarters · filed 2015-03-31 | -$3.29M derived: sum of 3 quarters · filed 2015-03-31 | -$4.71M 10-K · filed 2015-03-31 | -$86.04M 10-K · filed 2014-03-31 | ||||||||||||||
| 2013-09-30 | -$879.84K 10-Q · filed 2014-11-12 | -$2.29M derived: sum of 2 quarters · filed 2014-11-12 | -$3.71M 10-Q · filed 2014-11-12 | -$4.52M derived: sum of 4 quarters · filed 2014-11-12 | -$85.03M 10-Q · filed 2013-11-06 | ||||||||||||||
| 2013-06-30 | -$1.41M 10-Q · filed 2014-08-12 | -$2.83M 10-Q · filed 2014-08-12 | -$3.64M derived: sum of 3 quarters · filed 2014-08-12 | -$4.24M derived: sum of 4 quarters · filed 2014-08-12 | -$84.15M 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | -$1.42M 10-Q · filed 2014-05-14 | -$2.24M derived: sum of 2 quarters · filed 2014-05-14 | -$2.84M derived: sum of 3 quarters · filed 2014-05-14 | -$3.85M derived: sum of 4 quarters · filed 2014-05-14 | -$82.75M 10-Q · filed 2013-05-15 | ||||||||||||||
| 2012-12-31 | -$812.93K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.41M derived: sum of 2 quarters · filed 2014-03-31 | -$2.42M derived: sum of 3 quarters · filed 2014-03-31 | -$3.49M 10-K · filed 2014-03-31 | -$81.32M 10-K · filed 2013-04-03 | ||||||||||||||
| 2012-09-30 | -$601.18K 10-Q · filed 2013-11-06 | -$1.61M derived: sum of 2 quarters · filed 2013-11-06 | -$2.68M 10-Q · filed 2013-11-06 | -$3.65M derived: sum of 4 quarters · filed 2013-11-06 | -$80.51M 10-Q · filed 2012-11-21 | ||||||||||||||
| 2012-06-30 | -$1.01M 10-Q · filed 2013-08-14 | -$2.08M 10-Q · filed 2013-08-14 | -$3.05M derived: sum of 3 quarters · filed 2013-08-14 | -$4.27M derived: sum of 4 quarters · filed 2013-08-14 | -$79.91M 10-Q · filed 2012-08-13 | ||||||||||||||
| 2012-03-31 | -$1.07M 10-Q · filed 2013-05-15 | -$2.04M derived: sum of 2 quarters · filed 2013-05-15 | -$3.26M derived: sum of 3 quarters · filed 2013-05-15 | -$4.38M derived: sum of 4 quarters · filed 2013-05-15 | -$78.90M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | -$968.43K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-03 | -$2.19M derived: sum of 2 quarters · filed 2013-04-03 | -$3.31M derived: sum of 3 quarters · filed 2013-04-03 | -$4.44M 10-K · filed 2013-04-03 | -$77.83M 10-K · filed 2012-03-30 | ||||||||||||||
| 2011-09-30 | -$1.23M 10-Q · filed 2012-11-21 | -$2.34M derived: sum of 2 quarters · filed 2012-11-21 | -$3.47M 10-Q · filed 2012-11-21 | ||||||||||||||||
| 2011-06-30 | -$1.11M 10-Q · filed 2012-08-13 | -$2.24M 10-Q · filed 2012-08-13 | |||||||||||||||||
| 2011-03-31 | -$1.13M 10-Q · filed 2012-05-15 | ||||||||||||||||||
| 2010-12-31 | -$2.82M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |